Frequency of Metabolic Syndrome and Study of Anthropometric, Clinical and Biological Characteristics in Peri- and Postmenopausal Women in the City of Ksar El Kebir (Northern Morocco)

Abstract

This study aimed to determine the frequency of metabolic syndrome and to identify its predictive factors in peri- and post-menopausal women in the city of Ksar El Kebir, in northern Morocco. A total of 373 peri- and post-menopausal women between 45 and 64 years old participated in the study. Metabolic syndrome was diagnosed according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) definition. Body mass index (BMI) was calculated to assess the degree of obesity in women; anthropometric, clinical and biological parameters were collected during interviews. The mean ages of peri- and postmenopausal women were 48.84 ± 2.4 years and 56.65 ± 4.29 years, respectively. Postmenopausal women had higher means of anthropometric and biological parameters than peri-menopausal women. We also noted a predominance of metabolic syndrome in postmenopausal women (n = 158) compared to peri-menopausal women (n = 81). Waist circumference was the predominant marker in the subjects studied, whereas triglycerides were the lower marker. In the overall population, the incidence of metabolic syndrome and its associated factors were higher in postmenopausal women than in peri-menopausal women, from which it can be concluded that post menopause may be a predictor of metabolic syndrome.

Ultrasound Findings versus Hysteroscopic Guided Endometrial Histopathological Findings in Women with Postmenopausal Bleeding

“…The mean BMI of 30.17 km/m 2 observed in our study agrees with studies that have found a higher incidence of endometrial abnormalities in women with obesity (11).…”

Targeted Metabolomics Revealed a Sex-Dependent Signature for Metabolic Syndrome in the Mexican Population

“…However, this correlation was not observed in males and younger females with MetS; this could be attributed to changes in hormonal secretion and loss of estrogen in menopause, which causes an accumulation of visceral fat, leading to abdominal obesity [79,80]. Abdominal obesity is responsible for insulin resistance and the development of MetS [81]. Another possible explanation for the observed discrepancy can be attributed to sampling size, particularly in men with MetS.…”

The 100 top-cited articles in menopausal syndrome: a bibliometric analysis

“…Changes in hormone levels lead to abnormalities in lipid metabolism with elevated serum total cholesterol, LDL cholesterol, apolipoproteins, and triglycerides, and decreased high-density lipoprotein cholesterol (HDL-C) [ 91 ]. Reduced energy expenditure due to reduced lipid oxidation and reduced leptin sensitivity in menopausal women [ 92 ]. Postmenopausal women have a lower gut microbiome diversity, slightly similar to that of men, and are involved in sex hormone retention.…”